Pricing Log in Create free account

Dianthus Therapeutics, Inc. (DNTH) vs Legend Biotech Corporation Sponsored ADR (LEGN)

Dianthus Therapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Dianthus Therapeutics, Inc. and Legend Biotech Corporation Sponsored ADR are of similar size ($4.2B and $3.8B). Legend Biotech Corporation Sponsored ADR grew revenue faster over the last twelve months: 59.6% against −60.8%. Legend Biotech Corporation Sponsored ADR has the higher net margin (−7.20% vs −10,097.0%) and the higher return on invested capital (−9.54% vs −47.7%). Across the 17 metrics below, Legend Biotech Corporation Sponsored ADR leads on 12 and Dianthus Therapeutics, Inc. on 5.

Valuation

Metric DNTH LEGN Biotechnology median
P/E n/m n/m 8.50
P/S 2,121.40 2.72 9.71
P/B 3.45 2.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1,655.63 2.22 9.21
Earnings yield (5.76%) (2.68%) (33.15%)
Free cash flow yield (3.86%) (3.54%) (25.50%)

Profitability

Metric DNTH LEGN Biotechnology median
Gross margin 100.00% 56.58% 65.16%
Operating margin (11,441.39%) (5.06%) 0.00%
Net margin (10,096.95%) (7.20%) 0.00%
Free cash flow margin (8,177.99%) (9.58%) 0.00%
Return on equity (26.07%) (8.08%) (56.36%)
Return on assets (24.98%) (5.32%) (48.04%)
Return on invested capital (47.74%) (9.54%) 0.00%

Growth

Metric DNTH LEGN Biotechnology median
Revenue growth (TTM) (60.77%) 59.55% 6.02%
EPS growth (last fiscal year) (64.71%) (66.34%) 30.26%
Revenue growth, 5-year CAGR — 65.93% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNTH LEGN Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 26.10 3.04 4.72
Net debt to EBITDA 2.20 2.31 0.96

Dividend

Metric DNTH LEGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNTH LEGN Biotechnology median
Market cap 4.17b 3.84b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack